Back to top

Psychedelic: Helus Pharma reports FY26 financial results

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings results, a psilocybin ex...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

COMPASS Pathways PLC Sponsored ADR (CMPS)

Definium Therapeutics, Inc. (DFTX)

Cybin Inc. (HELP)